Big Pharma

President Donald Trump‘s $3.3 trillion domestic agenda bill, passed by House Republicans on Thursday, includes a significant but little-noticed victory for pharmaceutical companies that will cost taxpayers nearly $5 billion over the next decade. What Happened: The legislation expands...

A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has reignited discussions on Pharmacy Benefit Managers (...

Jim Cramer has raised concerns over the constitutionality of recent drug price controls, urging pharmaceutical companies to seek an injunction. What Happened:  CNBC’s Mad Money host, Cramer, in a post on X on Monday, argued that, unlike tariffs, drug price controls fall under the...

Mark Cuban, the billionaire entrepreneur, challenged Trump-supporter and political activist Charlie Kirk‘s stance on high drug prices, asserting that Pharmacy Benefit Managers (PBMs) are the main culprits, not Big Pharma. What Happened: Cuban criticized Kirk’s focus on Big...

Robert F. Kennedy Jr., President Donald Trump's pick for health secretary, addressed a wide range of medical-related topics on Wednesday during a confirmation hearing with the Senate Finance Committee. While Kennedy’s tone in each back-and-forth varied, depending on the senator, it was...

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) plans to land $4 billion in revenue by 2027. The company is targeting an adjusted operating margin of low-to-mid 40%’s (starting at 40% in 2026). The new structure, announced at an investor event Wednesday, covers three key business units. They...

On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine Gardasil. However, Merck still recorded a net quarterly loss due to...

As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall health of the planet that is only our home. This technology is being developed with the aim to reduce...

The announcement last week by the department of Health and Human Services (HHS) that it is now recommending the rescheduling of cannabis from schedule I to III, marks a significant inflection point for federal cannabis reform. The timing of the Drug Enforcement Agency (DEA...

The merger of Pfizer's Upjohn business with Mylan NV (NASDAQ: MYL), along with the potential of its COVID-19 vaccine candidate that it's developing with BioNTech, makes Pfizer a potential winner during COVID-19. Yet, Sanofi SA (NASDAQ: SNY) is considered by many to be the closest...

U.S. Army Spc. Brian Wilhelm was stationed in the Iraqi town of Balad when a rocket-propelled grenade blew up his leg. The pain was as bad as the actual injury that would eventually claim the demolished limb. Wilhelm was rushed to a MASH unit on the front. An Army colonel and anesthesiologist named...

You’ve seen the commercials: The antidepressant — oh, let’s call it Realitor — may cause suicide, explosive bowel syndrome, an erection lasting more than 72 days, lethargy, lumbago, listeria, hysteria, projectile vomiting and perhaps the plague. Consult your doctor if...